MOLLY MARANTO: Open Payments
NPI 1497788517 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 29 payments from 8 companies in 2025. Trend: 2023 $382 · 2024 $494 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $201 |
| Amgen Inc. | 5 | $82 |
| Lilly USA, LLC | 4 | $79 |
| Novo Nordisk Inc | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| PFIZER INC. | 2 | $35 |
| Itamar Medical Inc | 1 | $23 |
| ABBVIE INC. | 1 | $20 |
Products named: AIRSUPRA, OTEZLA, MOUNJARO, FARXIGA, Ozempic, TRELEGY ELLIPTA, ELIQUIS, WatchPATONE.
Industry payments across LA — which companies pay providers there.
